NCT05357794
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
701 public trials
104 recruiting studies
Lymphoma, T-Cell trial results
NCT06776952
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
NCT07093710
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China
NCT05157581
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Emory University School of Medicine Atlanta, Georgia, United States
- Cutaneous Translational Research Program - Johns Hopkins Medicine Baltimore, Maryland, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Recruiting
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
NCT00177268
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous T-Cell Lymphoma, +23 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT07253129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Recruiting
Amping up With PemJAK
NCT07283822
- Conditions
- Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
NCT06421948
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
- Liling Zhang Wuhan, Hubei, China
- Yajun Li Changsha, Hunan, China
- Ming Jiang Chengdu, Sichuan, China
Recruiting
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
NCT04925609
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Granuloma, Granuloma, Plasma Cell, +15 more
- Locations
-
- Institut Gustave Roussy Paris, France
- Princess Máxima Center for Pediatric Oncology Utrecht, Netherlands
NCT06588868
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +13 more
- Locations
-
- AOU Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale Bari, Italy
- Policlinico S.Orsola-Malpighi - Istituto di Ematologia Bologna, Italy